Activated protein C resistance and adverse pregnancy outcome

American Journal of Obstetrics and Gynecology

Volumn 177, Issue 1, 1997, Pages 170-173

  Rotmensch, S ^a   Liberati, M ^a   Mittelmann, M ^a   Ben Rafael, Z ^a  

^a RABIN MEDICAL CENTER   (Israel)

Author keywords

Activated protein C resistance; Pregnancy outcome; Thromboembolism

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5; ESTROGEN; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL ARTICLE; FEMALE; FETUS DEATH; GENETIC DISORDER; GENOTYPE; HUMAN; INTRAUTERINE GROWTH RETARDATION; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; THROMBOEMBOLISM; THROMBOPHILIA; THROMBOSIS;

EID: 0030790168     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(97)70457-5     Document Type: Article

References (17)

1. CJ Lockwood JH. Rand The immunobiology and obstetrical consequences of antiphospholipid antibodies Obstet Gynecol Surv 49 1994 432 441
2. B Dahlback M Carlsson PJ. Svensson Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C Proc Natl Acad Sci U S A 90 1993 1004 1008
3. RM Bertina BPC Koeleman T. Koster Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 1994 64 67
4. B Zoller PJ Svensson X He B. Dahlback Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C J Clin Invest 94 1994 2521 2524
5. PJ Svensson B. Dahlback Resistance to activated protein C as a basis for venous thrombosis N Engl J Med 330 1994 517 522
6. WE Brenner DA Edelman CH. Hendricks A standard of fetal growth for the United States of America Am J Obstet Gynecol 126 1976 555 564
7. American College of Obstetricians and Gynecologists Management of preeclampsia 1986 American College of Obstetricians and Gynecologists Washington Technical Bulletin No. 91
8. T Koster FR Rosendaal H de Ronde E Briet JP Vandenbroucke R. Bertina Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study Lancet 342 1994 1503 1506
9. JH Griffin B Evatt C Widerman JA. Fernandez Anticoagulant protein C pathway defective in majority of thrombophilic patients Blood 82 1993 1989 1993
10. B Zoller B. Dahlback Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis Lancet 343 1994 1536 1538
11. M Hellgren PJ Svensson B. Dahlback Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives Am J Obstet Gynecol 173 1995 210 213
12. D Dizon-Townson S Kinney DW Branch K. Ward The factor V Leiden mutation is not associated with idiopathic recurrent miscarriage [abstract] Am J Obstet Gynecol 174 1996 360
13. HJ Out CD Koojiman HW. Bruinse Histopathological findings in placentae from patients with intrauterine fetal death and antiphospholipid antibodies Eur J Obstet Gynecol 41 1991 179 186
14. F De Wolf LO Carreras P. Moerman Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant Am J Obstet Gynecol 142 1982 829 834
15. M Vasse O Leduc JY Borg MH Chretien M. Monconduit Resistance to activated protein C: evaluation of three functional assays Thromb Res 76 1994 47 59
16. AM Cumming RC Tait S Fildes A Yoong S Keeney CR. Hay Development of resistance to activated protein C during pregnancy Br J Haematol 90 1995 725 727
17. JS Greengard S Eichinger JH Griffin KA. Bauer Brief report: variability of thrombosis among homozygous siblings with resistance to activated protein C due to an ARG ▶ Gln mutation in the gene for factor V N Engl J Med 331 1995 1559 1561